Skip to main content

Table 4 Demographic details of asthma patients

From: Prevalence of gastro-oesophageal reflux disease symptoms and reflux-associated respiratory symptoms in asthma

 

Asthmatics with GORD score

> 12.5 (n = 120)

Asthmatics with GORD score

<12.5 (n = 82)

P value

Age, yrs; mean (SD)

34.4 (11.4)

35.6 (11.8)

0.318

Males/females

53/67

36/46

1.000

BMI, kg/m2; mean (SD)

21.9 (3.3)

22.6 (2.5)

0.126

Current smoker (% of subjects)

13.3

11.0

0.630

Current drinker (% of subjects)

20.0

7.3

0.040*

Asthma severity (% of subjects)

   

   Mild intermittent

66.7

89.0

0.001

   Mild persistent

22.5

9.8

 

   Moderate or severe persistent

10.8

1.2

 

Asthma medication (% of subjects)

   

   Oral salbutamol

68.3

50.0

0.009*

   Inhaled salbutamol

53.3

62.2

0.212

   Oral theophylline

33.3

28.0

0.426

   Oral steroids

18.3

9.8

0.092

   Inhaled steroids

40.0

34.1

0.399

  1. * Chi squared test